We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Dechra Pharmaceuticals Plc | LSE:DPH | London | Ordinary Share | GB0009633180 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 3,866.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMDPH TIDMAV.
RNS Number : 6554X
Dechra Pharmaceuticals PLC
23 February 2017
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i) -------------------------------------------------- 1. Identity of the issuer or Dechra Pharmaceuticals the underlying issuer plc of existing shares to which voting rights are attached: (ii) ----------------------------------------------------------------- -------------------------------- 2 Reason for the notification (please tick the appropriate box or boxes): --------------------------------------------------------------------------------------------------- An acquisition or disposal of voting rights -------------------------------------------------------------------- ----------------------------- An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached -------------------------------------------------------------------- ----------------------------- An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments -------------------------------------------------------------------- ----------------------------- An event changing the breakdown of voting rights -------------------------------------------------------------------- ----------------------------- Other (please specify): ----------------------------------------------------------- ------- ----------------------------- 3. Full name of person(s) Aviva plc & its subsidiaries subject to the notification obligation: (iii) ------------------------------------------------------------- ------------------------------------ 4. Full name of shareholder(s) Registered Holder: (if different from 3.):(iv) Chase (GA Group) Nominees Limited 2,070,968* Chase Nominees Limited 21,988* HSBC Global Custody Nominee (UK) Limited 494,541* Street Nominees Limited 227,684* Available Upon Request 7,446* * denotes direct interest ------------------------------------------------------------- ------------------------------------ 5. Date of the transaction 21 February 2017 and date on which the threshold is crossed or reached: (v) ------------------------------------------------------------- ------------------------------------ 6. Date on which issuer 22 February 2017 notified: ------------------------------------------------------------- ------------------------------------ 7. Threshold(s) that is/are <3% to >3% Change at Direct crossed or Interest Level reached: (vi, vii) ------------------------------------------------------------- ------------------------------------ 8. Notified details: -------------------------------------------------------------------------------------------------------------- A: Voting rights attached to shares (viii, ix) -------------------------------------------------------------------------------------------------------------- Class/type Situation previous Resulting situation after the of to the triggering triggering transaction shares transaction if possible using the ISIN CODE -------------- ------------------------------ -------------------------------------------------------------- Number Number Number Number of voting % of voting of of of shares rights rights (x) Shares Voting Rights -------------- --------------- ------------- ----------- ------------------------- ---------------------- Direct Direct Indirect Direct Indirect (xi) (xii) -------------- -------------- ------------ ----------- ---------- ------------- ------- ------------- Ordinary Shares Below Below Not Not GB0009633180 Threshold Threshold 2,822,627 2,822,627 Disclosable 3.03% Disclosable --------------- ------------- ----------- ---------- ------------- ------- ------------- B: Qualifying Financial Instruments -------------------------------------------------------------------------------------------------------------- Resulting situation after the triggering transaction -------------------------------------------------------------------------------------------------------------- Type of Expiration Exercise/ Number of voting % of voting financial date Conversion rights that rights instrument (xiii) Period (xiv) may be acquired if the instrument is exercised/ converted. --------------- --------------- ------------------------- ------------------------- ---------------------- RIGHT TO 159,637 * RECALL LOANED SHARES N/A N/A * Direct Interest 0.17% --------------- --------------- ------------------------- ------------------------- ---------------------- C: Financial Instruments with similar economic effect to Qualifying Financial Instruments (xv, xvi) ----------------------------------------------------------------------------------------------- Resulting situation after the triggering transaction ----------------------------------------------------------------------------------------------- Type of financial Exercise Expiration Exercise/ Number of voting % of voting instrument price date Conversion rights instrument rights (xix, (xvii) period refers to xx) (xviii) ------------------ --------- ----------- ------------ ------------------- ---------------- Nominal Delta ------------------ --------- ----------- ------------ ------------------- -------- ------ Total (A+B+C) ------------------------------------------------------ Number of voting rights Percentage of voting rights ------------------------ ---------------------------- 2,982,264 3.20% ------------------------ ---------------------------- 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: (xxi) -------------------------------------------------------------------- The voting rights are managed and controlled by Aviva Investors Global Services Limited and Friends Provident International Limited, with the following chains of controlled undertakings:- Aviva Investors Global Services Limited: * Aviva plc (Parent Company) * Aviva Group Holdings Limited (wholly owned subsidiary of Aviva plc) * Aviva Investors Holdings Limited (wholly owned subsidiary of Aviva Group Holdings Limited) * Aviva Investors Global Services Limited (wholly owned subsidiary of Aviva Investors Holdings Limited) Friends Provident International Limited: * Aviva plc (Parent Company) * Aviva Group Holdings Limited (wholly owned subsidiary of Aviva plc) * Friends Provident International Limited (wholly owned subsidiary of Aviva Group Holdings Limited) Proxy Voting: -------------------------------------------------------------------- 10. Name of the proxy holder: See Section 4 ------------------------------------------------ ------------------ 11. Number of voting rights proxy holder will cease to hold: ------------------------------------------------ ------------------ 12. Date on which proxy holder will cease to hold voting rights: ------------------------------------------------ ------------------ 13. Additional information: Figures are based on a total number of voting rights of
93,059,190 as per the Company's Total Voting Rights Announcement of 31 January 2017. ------------------------------- ---------------------------------- 14. Contact name: Neil Whittaker, Aviva plc ------------------------------- ---------------------------------- 15. Contact telephone number: 01603 684420 ------------------------------- ----------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLDMGZZRFNGNZG
(END) Dow Jones Newswires
February 23, 2017 03:53 ET (08:53 GMT)
1 Year Dechra Pharmaceuticals Chart |
1 Month Dechra Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions